We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Takeda, Sanford-Burnham Launch Heart Failure Collaboration
News

Takeda, Sanford-Burnham Launch Heart Failure Collaboration

Takeda, Sanford-Burnham Launch Heart Failure Collaboration
News

Takeda, Sanford-Burnham Launch Heart Failure Collaboration

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Takeda, Sanford-Burnham Launch Heart Failure Collaboration"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Sanford-Burnham Medical Research Institute at Lake Nona said today it is launching a two-year partnership with Takeda Pharmaceutical focused on treating heart failure. The value of the collaboration was not disclosed.

Researchers from Takeda and Sanford-Burnham will join colleagues from the institute’s Conrad Prebys Center for Chemical Genomics to screen its library of compounds.

The researchers aim to identify a molecule that can reactivate metabolism in heart failure patients by restoring the heart’s ability to burn nutritional fuels for pump function.

“My team and colleagues at the Institute have been studying the machinery that controls metabolism in the heart for years. The partnership with Takeda will accelerate our progress and bring it closer to the clinic,” Daniel P. Kelly, M.D., Tavistock distinguished professor and scientific director of Sanford-Burnham at Lake Nona, said in a statement.

The new collaboration is the third between Sanford-Burnham and Takeda over the past five years. The partners launched their first collaboration in 2011, focused on identifying and validating obesity-related biomarkers and new drug targets, as well as speeding up development of new obesity treatments along with Florida Hospital—with which the institute runs a Translational Research Institute for Metabolism and Diabetes. The partnership was renewed in 2013.

Advertisement